Screening of the used pattern of Kokilaksha (Asteracantha longifolia Nees.) containing formulations through Ayurved compendium

Jayshri Nakum; Kruti Vyas; Bharti Umretia; Bharat Kalsariya

Abstract

Ayurveda is the science of life, addresses the holistic perspective on well-being. It encompasses the pathology and numerous physiologies of diseases, along with their therapies. According to conventional medicine, plant extracts have been used to treat a number of illnesses since antiquity. Therefore, research on traditionally used medicinal plants is significant for two reasons: first, it might lead to the development of novel chemotherapy-related drugs; and second, it might provide insight into potential safety concerns with the use of medicinal plants in the future. The plant Kokilaksha (Asteracantha longifolia Nees.) is an annual herb utilised in Ayurveda and other Indian medical systems also. It is a potential medicinal plant belong to Acanthaceae family, which has been employed effectively for its therapeutic potency across a wide spectrum of ailments. The plant Kokilaksha has a lot to offer the medical community due to its widespread availability, economic significance, and therapeutic efficacy. Various formulations of Kokilaksha like Swarasa (Juice), Kalka (Paste), Kwatha (Decoction), Churna (Powder), Bhasma (Ash), Taila (Oil), Ghrita (Ghee) and many more have been used as Vajikarana (Aphrodisiac) and also in the treatment of Mootrakrichchha (Dysuria), Ashmari (Stone), Vatarakta (Gout), Shotha (Inflammation) and other diseases. In view of this, the present review is aimed to screen the used pattern of Kokilaksha containing formulations from 27 classical texts of Ayurved compendium. This screening has brought to light that Churna and Kwatha are out of 103 formulations the most used formulations of Kokilaksha. Hence, this review gives insight to the researchers for understanding the possible modification in drug development of Kokilaksha which are not explored till date scientifically